Transmembrane protein 191A (TMEM191A)

Transmembrane protein 191A (TMEM191A) is classified in public gene databases as a pseudogene rather than a protein-coding gene or established receptor/enzyme[1]. No evidence is available suggesting that TMEM191A encodes a functional protein, nor does it appear in canonical lists of transmembrane protein therapeutic targets, ion channels, receptors, or other well-characterized molecular families. There is no published data on biological function, involvement in disease processes, drug interactions, or mechanisms of action. The gene is listed with aliases (TMEM191A, DKFZp434N035, TMEM191AP) but is not recognized as a validated therapeutic target in biomedical research.\nKey context and limitations:\n- The identification of TMEM191A as a pseudogene (by authoritative sources such as GeneCards and Ensembl) means it does not code for a functional protein and should not be considered a therapeutic target[1].\n- No literature or database entries describe a role for TMEM191A in cell signaling, disease, or pharmacology.\n- This name is sometimes mistaken for related TMEM191 family members, but only TMEM191B and TMEM191C are annotated as protein-coding genes[4]. If the query intends a different protein target, the correct canonical name and relevant information should be supplied.\nSummary assessment:\nTMEM191A does not represent a functional molecule or receptor, and there is a fundamental issue with the query: it is not a valid therapeutic target, nor does it encode a protein, making "is_target=false" and "is_incorrect=true" the appropriate assignments[1].

Other names

TMEM191ADKFZp434N035TMEM191AP